| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.54B | 14.69B | 15.39B | 14.12B | 13.68B | 12.67B |
| Gross Profit | 961.00M | 928.00M | 1.03B | 807.00M | 826.00M | 592.00M |
| EBITDA | 384.00M | 656.00M | 828.00M | 603.00M | 2.02B | 119.00M |
| Net Income | -281.00M | 18.00M | 205.00M | -120.00M | 1.11B | -486.00M |
Balance Sheet | ||||||
| Total Assets | 8.95B | 9.35B | 9.42B | 9.16B | 10.78B | 10.26B |
| Cash, Cash Equivalents and Short-Term Investments | 958.00M | 945.00M | 1.11B | 947.00M | 1.52B | 1.69B |
| Total Debt | 2.40B | 2.40B | 2.54B | 2.58B | 3.70B | 4.31B |
| Total Liabilities | 6.80B | 6.82B | 6.82B | 6.74B | 7.82B | 8.68B |
| Stockholders Equity | 1.77B | 2.13B | 2.23B | 2.07B | 2.38B | 1.21B |
Cash Flow | ||||||
| Free Cash Flow | 205.00M | 277.00M | 415.00M | 47.00M | 0.00 | -80.00M |
| Operating Cash Flow | 450.00M | 543.00M | 667.00M | 274.00M | 260.00M | 246.00M |
| Investing Cash Flow | -186.00M | -253.00M | -229.00M | 484.00M | 347.00M | 166.00M |
| Financing Cash Flow | -268.00M | -502.00M | -271.00M | -1.27B | -770.00M | 393.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $6.07B | 14.33 | 8.96% | 2.63% | -1.90% | -13.86% | |
73 Outperform | $2.48B | 8.16 | 23.16% | 0.57% | -4.03% | -39.51% | |
72 Outperform | $9.05B | 13.31 | 40.38% | 1.07% | -4.21% | -0.45% | |
65 Neutral | $10.14B | 75.97 | 2.24% | 1.24% | 0.08% | -83.69% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $1.65B | -6.23 | -14.41% | ― | -1.04% | -1510.41% | |
53 Neutral | $3.38B | 65.41 | -4.82% | 1.70% | -18.23% | ― |
On January 15, 2026, Adient and certain subsidiaries amended their existing term loan credit agreement, keeping total outstanding borrowings at $624 million while securing a reduction in the interest rate margin to 2.00% for Term SOFR loans and 1.00% for base rate loans. The obligations under the credit agreement remain secured and guaranteed by Adient plc and key wholly owned restricted subsidiaries, a move that lowers financing costs and supports the company’s capital structure without increasing its debt load, which may enhance financial flexibility for operations and stakeholders.
The most recent analyst rating on (ADNT) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.
On October 17, 2025, Adient US LLC and Adient plc, along with other loan parties, amended their existing revolving credit agreement with JPMorgan Chase Bank. The amendment extends the maturity date by five years and reduces the aggregate commitments to $1 billion, maintaining secured guarantees by the company and its subsidiaries.
The most recent analyst rating on (ADNT) stock is a Sell with a $20.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.